Adamant Biomedical Investments
Latest statistics and disclosures from Adamant Biomedical Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Celgene Corporation, BIIB, GILD, AMGN, Actavis, and represent 20.15% of Adamant Biomedical Investments's stock portfolio.
- Added to shares of these 10 stocks: Hospira (+$5.5M), ACAD (+$5.4M), WuXi PharmaTech, Medivation, LGND, ABBV, ELV, Catamaran, Akorn, Clovis Oncology.
- Started 13 new stock positions in WuXi PharmaTech, Hospira, Quintiles Transnatio Hldgs I, Asterias Biotherapeutics, Biotime Inc wts oct 1 18, THC, ELV, Health Net, PAREXEL International Corporation, Clovis Oncology. ABBV, Ims Health Holdings, LGND.
- Reduced shares in these 10 stocks: Covidien (-$5.1M), , BIB, TEVA, Salix Pharmaceuticals, Qiagen, , CNC, RVNC, ISIS Pharmaceuticals.
- Sold out of its positions in Dendreon Corporation, TNA, PODD, Ldr Hldg, Organovo Holdings, RVNC, WellPoint, Wright Medical.
- Adamant Biomedical Investments was a net seller of stock by $-21M.
- Adamant Biomedical Investments has $418M in assets under management (AUM), dropping by 4.42%.
- Central Index Key (CIK): 0001542336
Portfolio Holdings for Adamant Biomedical Investments
Adamant Biomedical Investments holds 101 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Celgene Corporation | 5.0 | $21M | -9% | 186k | 111.86 |
|
| Biogen Idec (BIIB) | 4.3 | $18M | -3% | 53k | 339.46 |
|
| Gilead Sciences (GILD) | 4.1 | $17M | -8% | 180k | 94.26 |
|
| Amgen (AMGN) | 3.6 | $15M | -5% | 95k | 159.29 |
|
| Actavis | 3.2 | $13M | 52k | 257.41 |
|
|
| UnitedHealth (UNH) | 2.8 | $12M | -10% | 115k | 101.09 |
|
| Mylan | 2.7 | $11M | -13% | 200k | 56.37 |
|
| Catamaran | 2.6 | $11M | +51% | 207k | 51.91 |
|
| Alexion Pharmaceuticals | 2.5 | $11M | -5% | 57k | 185.04 |
|
| Medtronic | 2.1 | $8.8M | -19% | 122k | 72.20 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.1 | $8.7M | 73k | 118.79 |
|
|
| Regeneron Pharmaceuticals (REGN) | 2.1 | $8.6M | +16% | 21k | 410.24 |
|
| McKesson Corporation (MCK) | 2.0 | $8.5M | 41k | 207.59 |
|
|
| Auris Med Hldg | 2.0 | $8.5M | 2.2M | 3.90 |
|
|
| Mallinckrodt Pub | 1.9 | $7.9M | 80k | 99.02 |
|
|
| Abbott Laboratories (ABT) | 1.9 | $7.8M | -13% | 173k | 45.02 |
|
| Allergan | 1.8 | $7.4M | 35k | 212.60 |
|
|
| Illumina (ILMN) | 1.8 | $7.4M | -6% | 40k | 184.58 |
|
| ACADIA Pharmaceuticals (ACAD) | 1.6 | $6.5M | +485% | 205k | 31.75 |
|
| Medivation | 1.6 | $6.5M | +225% | 65k | 99.62 |
|
| Cardinal Health (CAH) | 1.5 | $6.5M | -23% | 80k | 80.72 |
|
| ISIS Pharmaceuticals | 1.5 | $6.2M | -28% | 100k | 61.74 |
|
| Akorn | 1.4 | $5.8M | +166% | 160k | 36.20 |
|
| Eli Lilly & Co. (LLY) | 1.3 | $5.5M | 80k | 68.99 |
|
|
| Hospira | 1.3 | $5.5M | NEW | 90k | 61.24 |
|
| Centene Corporation (CNC) | 1.3 | $5.4M | -34% | 52k | 103.86 |
|
| Salix Pharmaceuticals | 1.2 | $5.2M | -42% | 45k | 114.93 |
|
| CIGNA Corporation | 1.2 | $5.1M | 50k | 102.92 |
|
|
| Incyte Corporation (INCY) | 1.2 | $5.1M | 70k | 73.11 |
|
|
| Molina Healthcare (MOH) | 1.2 | $4.9M | -30% | 92k | 53.53 |
|
| Express Scripts Holding | 1.1 | $4.8M | 57k | 84.67 |
|
|
| Baxter International (BAX) | 1.1 | $4.8M | 65k | 73.29 |
|
|
| Brookdale Senior Living (BKD) | 1.1 | $4.8M | -5% | 130k | 36.67 |
|
| WuXi PharmaTech | 1.1 | $4.7M | NEW | 140k | 33.67 |
|
| Humana (HUM) | 1.0 | $4.3M | -14% | 30k | 143.63 |
|
| Ligand Pharmaceuticals In (LGND) | 1.0 | $4.3M | NEW | 81k | 53.21 |
|
| Johnson & Johnson (JNJ) | 1.0 | $4.2M | -11% | 40k | 104.58 |
|
| Lannett Company | 1.0 | $4.0M | +17% | 94k | 42.88 |
|
| Hca Holdings (HCA) | 1.0 | $4.0M | +22% | 55k | 73.38 |
|
| Stryker Corporation (SYK) | 0.9 | $3.9M | -27% | 42k | 94.34 |
|
| Abbvie (ABBV) | 0.9 | $3.9M | NEW | 60k | 65.43 |
|
| Aetna | 0.9 | $3.9M | -26% | 44k | 88.84 |
|
| Anthem (ELV) | 0.9 | $3.8M | NEW | 30k | 125.67 |
|
| Bristol Myers Squibb (BMY) | 0.8 | $3.5M | +20% | 60k | 59.03 |
|
| Perrigo Company (PRGO) | 0.8 | $3.3M | -34% | 20k | 166.65 |
|
| St. Jude Medical | 0.8 | $3.3M | -21% | 51k | 65.04 |
|
| BioMarin Pharmaceutical (BMRN) | 0.8 | $3.3M | -28% | 36k | 90.39 |
|
| Jazz Pharmaceuticals (JAZZ) | 0.8 | $3.3M | 20k | 163.75 |
|
|
| Teva Pharmaceutical Industries (TEVA) | 0.7 | $2.9M | -58% | 50k | 57.52 |
|
| CVS Caremark Corporation (CVS) | 0.7 | $2.9M | -33% | 30k | 96.30 |
|
| Endo International (ENDPQ) | 0.7 | $2.9M | 40k | 72.12 |
|
|
| Zimmer Holdings (ZBH) | 0.7 | $2.8M | 25k | 113.44 |
|
|
| Clovis Oncology | 0.7 | $2.8M | NEW | 50k | 56.00 |
|
| Alkermes (ALKS) | 0.6 | $2.6M | 45k | 58.56 |
|
|
| Cerner Corporation | 0.6 | $2.6M | 40k | 64.65 |
|
|
| Dr. Reddy's Laboratories (RDY) | 0.6 | $2.5M | -37% | 50k | 50.44 |
|
| Cubist Pharmaceuticals | 0.6 | $2.4M | 24k | 100.67 |
|
|
| Shire | 0.6 | $2.3M | 11k | 212.55 |
|
|
| Qiagen | 0.6 | $2.3M | -60% | 100k | 23.43 |
|
| Merck & Co (MRK) | 0.5 | $2.3M | 40k | 56.80 |
|
|
| PAREXEL International Corporation | 0.5 | $2.2M | NEW | 40k | 55.55 |
|
| Alnylam Pharmaceuticals (ALNY) | 0.5 | $2.2M | 23k | 97.00 |
|
|
| Intuitive Surgical (ISRG) | 0.5 | $2.1M | 4.0k | 529.00 |
|
|
| Ariad Pharmaceuticals | 0.5 | $2.1M | 300k | 6.87 |
|
|
| DaVita (DVA) | 0.5 | $2.0M | 26k | 75.73 |
|
|
| Pfizer (PFE) | 0.5 | $1.9M | 60k | 31.15 |
|
|
| Proshares Tr pshs ult nasb (BIB) | 0.5 | $1.9M | -70% | 15k | 125.47 |
|
| Edwards Lifesciences (EW) | 0.4 | $1.8M | 15k | 127.38 |
|
|
| Tenet Healthcare Corporation (THC) | 0.4 | $1.8M | NEW | 35k | 50.66 |
|
| Varian Medical Systems | 0.4 | $1.7M | 20k | 86.50 |
|
|
| C.R. Bard | 0.4 | $1.7M | 10k | 166.60 |
|
|
| Omnicare | 0.4 | $1.7M | +27% | 23k | 72.91 |
|
| Health Net | 0.4 | $1.6M | NEW | 30k | 53.53 |
|
| MannKind Corporation | 0.4 | $1.6M | 300k | 5.21 |
|
|
| athenahealth | 0.3 | $1.5M | 10k | 145.70 |
|
|
| Medicines Company | 0.3 | $1.4M | 50k | 27.68 |
|
|
| Seattle Genetics | 0.3 | $1.3M | 40k | 32.12 |
|
|
| NPS Pharmaceuticals | 0.3 | $1.2M | 34k | 35.76 |
|
|
| Achillion Pharmaceuticals | 0.3 | $1.2M | +25% | 100k | 12.25 |
|
| ResMed (RMD) | 0.3 | $1.1M | -66% | 20k | 56.05 |
|
| Neurocrine Biosciences (NBIX) | 0.2 | $1.0M | 45k | 22.33 |
|
|
| Covidien | 0.2 | $1.0M | -83% | 10k | 102.30 |
|
| AmerisourceBergen (COR) | 0.2 | $902k | 10k | 90.20 |
|
|
| United Therapeutics Corporation (UTHR) | 0.2 | $906k | -53% | 7.0k | 129.43 |
|
| Myriad Genetics (MYGN) | 0.2 | $817k | 24k | 34.04 |
|
|
| Immunomedics | 0.2 | $720k | 150k | 4.80 |
|
|
| WellCare Health Plans | 0.2 | $656k | 8.0k | 82.00 |
|
|
| Impax Laboratories | 0.1 | $634k | 20k | 31.70 |
|
|
| Halozyme Therapeutics (HALO) | 0.1 | $579k | 60k | 9.65 |
|
|
| Quintiles Transnatio Hldgs I | 0.1 | $589k | NEW | 10k | 58.90 |
|
| Celldex Therapeutics | 0.1 | $548k | 30k | 18.27 |
|
|
| Affymetrix | 0.1 | $494k | -50% | 50k | 9.88 |
|
| Theravance | 0.1 | $495k | -65% | 35k | 14.14 |
|
| Exelixis (EXEL) | 0.1 | $432k | 300k | 1.44 |
|
|
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $287k | 17k | 16.88 |
|
|
| Ims Health Holdings | 0.1 | $256k | NEW | 10k | 25.60 |
|
| Theravance Biopharma (TBPH) | 0.0 | $171k | 11k | 14.96 |
|
|
| Geron Corporation (GERN) | 0.0 | $146k | 45k | 3.24 |
|
|
| Cubist Pharmaceutic-cvr | 0.0 | $3.2k | 80k | 0.04 |
|
|
| Asterias Biotherapeutics | 0.0 | $6.0k | NEW | 1.9k | 3.20 |
|
| Biotime Inc wts oct 1 18 | 0.0 | $2.0k | NEW | 2.3k | 0.87 |
|
Past Filings by Adamant Biomedical Investments
SEC 13F filings are viewable for Adamant Biomedical Investments going back to 2014
- Adamant Biomedical Investments 2014 Q4 filed Feb. 13, 2015
- Adamant Biomedical Investments 2014 Q3 filed Nov. 14, 2014